Bioventus (BVS) Acquisitions (2021 - 2022)
Bioventus (BVS) posted Acquisitions of $104.6 million for Q4 2022, up 2092300.0% on a QoQ basis from -$5000.0 in Q3 2022, and up 328.46% year-over-year from $24.4 million in Q4 2021.
Bioventus (BVS) Acquisitions (2021 - 2022) Analysis & Trends
Bioventus' Acquisitions history runs 2 years deep, the most recent figure standing at $104.6 million for Q4 2022.
- Quarterly Acquisitions rose 328.46% year-over-year to $104.6 million in Q4 2022, while the trailing twelve-month figure through Oct 2022 was $367.7 million (changed N/A YoY) and the FY2021 annual result came in at $262.9 million, changed N/A from the prior year.
- Acquisitions was $104.6 million for Q4 2022 at Bioventus, up from -$5000.0 in the prior quarter.
- Across five years, Acquisitions topped out at $262.9 million in Q4 2021 and bottomed at -$45.8 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | 2.30 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | -268.10 Mn |
| 10 | Bioventus | 825.05 Mn | 789.21 Mn | 90.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 1, 2022 | 104.61 Mn |
| Jul 2, 2022 | -5,000.00 |
| Apr 2, 2022 | 236,000.00 |
| Dec 31, 2021 | 262.87 Mn |
| Oct 2, 2021 | -45.79 Mn |
| Jul 3, 2021 | -1,000.00 |
| Apr 3, 2021 | 45.79 Mn |